학술논문
Independent validation of the HER2DX genomic test in HER2-positive breast cancer treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): a correlative analysis from the DAPHNe phase II clinical trial
Document Type
Journal
Author
Waks, Adrienne; Ogayo, Esther R.; Pare, Laia; Marin-Aguilera, Mercedes; Braso-Maristany, Fara; Galvan, Patricia; Castillo, Oleguer; Martinez-Saez, Olga; Vivancos, Ana; Villagrasa, Patricia; Tarantino, Paolo; Desai, Neelam; Guerriero, Jennifer; Metzger, Otto; Tung, Nadine; Krop, Ian; Parker, Joel S.; Perou, Charles M.; Prat, Aleix; Winer, Eric; Tolaney, Sara; Mittendorf, Elizabeth A.
Source
Subject
Language
English
ISSN
15387445